Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by TechOneon Jan 09, 2025 1:53pm
126 Views
Post# 36396475

Spectral on Linkedin Today

Spectral on Linkedin Today A Persistent Threat in Hospitals
The sobering reality of sepsis:

- A leading cause of death in hospitals.
- Impacts at least 1.7 million adults in the U.S. annually.
- 350,000+ lives lost each year.
1 in 3 hospital deaths involves a patient with sepsis.
- A major driver of hospital readmissions.

Every number represents a patient, a family, a story. Together, we can improve early detection, innovate treatment options, and save lives.

At Spectral Medical, we’re committed to advancing solutions for sepsis and septic shock, including endotoxic septic shock (ESS), one of its most severe and difficult-to-treat forms.

Let’s keep pushing the boundaries of what’s possible in critical care.

How is your institution addressing the sepsis challenge?
<< Previous
Bullboard Posts
Next >>